Pre-exposure prophylaxis (prep) for HIV infection: Results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices

AIDS Patient Care and STDs

Volumn 27, Issue 10, 2013, Pages 553-559

  Tellalian, David ^a   Maznavi, Khalid ^b   Bredeek, U Fritz ^c   Hardy, W David ^a,d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b TORRANCE MEMORIAL MEDICAL CENTER   (United States)

^c Metropolis Medical   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; DRUG EFFICACY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HEPATITIS B; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT PREFERENCE; POST EXPOSURE PROPHYLAXIS; PRE EXPOSURE PROPHYLAXIS; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PROPHYLAXIS; SEXUALLY TRANSMITTED DISEASE; TREATMENT REFUSAL; VIRUS TRANSMISSION; AGED; ATTITUDE TO HEALTH; CLINICAL PRACTICE; HIV INFECTIONS; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; VIROLOGY;

ADULT; AGED; ANTI-HIV AGENTS; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 84885218800     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0173     Document Type: Article

References (25)

1. Moore R. Epidemiology of HIV infection in the United States: Implications for linkage to care. Clin Infect Dis 2011;52:S208-S213.
2. Celum C, Baeten J. Tenofovir-based pre-exposure prophylaxis for HIV prevention: Evidence and evolving questions. Curr Opin Infect Dis 2012;25:51-57.
3. Grant RM. Antiretroviral agents used by HIV-uninfected persons for prevention: Pre-and postexposure prophylaxis. Clin Infect Dis 2010;50:S96-S101.
4. Grant MD, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
5. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399-410.
6. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012;367:423-434.
7. Karim QA, Karim SA, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329: 1168-1174.
8. Centers for Disease Control and Prevention. Interim Guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011;60:65-68.
9. U.S. Food and Drug Administration. FDA Approves First Drug for Reducing the Risk of Sexually Acquired HIV Infection, July 16, 2012. Available at: http://www.fda .gov/NewsEvents/Newsroom/PressAnnouncements/ucm 312210.htm 10.
10. Damme LV, Corneli A, Ahmed K, et al. Pre-exposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367:411-422.
11. Daily HIV Prevention Approaches Didn't Work for African Women in the VOICE Study. Microbicide Trials Network, March 4, 2013. Available at: http://www.mtnstopshiv.org/node/4877.
12. Myers GM, Mayer KH. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: Current considerations in light of new findings. AIDS Patient Care STDs 2011;25:63-71.
13. Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS ONE 2012;7:e40603.
14. FHI Statement on the FEM-PrEP HIV Prevention Study. Family Health International, April 18, 2011. Available at: http://www.fhi360.org/fhi- statement-fem-prep-hiv-preventionstudy.
15. IAS 2011 Press Release, July 18, 2011. Available at: http://www.ias2011. org/WebContent/File/ias2011-Antiretroviral% 20Treatment%20is%20HIV%20Prevention%20-%20The%20 proof%20is%20here.pdf.
16. Rey D. Post-exposure prophylaxis for HIV infection. Exp Rev Anti-infect Ther 2011;9:431-442.
17. White J, Mimiaga MJ, Krakower DS, et al. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDs 2012;26:395-405.
18. Tripathi A, Ogbuanu C, Monger M, et al. Preexposure prophylaxis for HIV infection: Healthcare providers' knowledge, rerception, and willingness to adopt future implementation in the southern US. South Med J 2012;105: 199-206.
19. Calderon Y, Leider J, Cowan E, et al. HIV pre-exposure prophylaxis (PrEP)-Knowledge and attitudes among a New York City Emergency Department patient population. Retrovirology 2012;9:P94.
20. Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for Implementation. Implement Sci 2012;7:116.
21. Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: A mixed methods study. PLoS ONE 2012;7:e50061.
22. Brooks RA, Landovitz RJ, Kaplan RL, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: A mixed methods study. AIDS Patient Care STDs 2012;26:87-94.
23. Khawcharoenporn T, Kendrick S, Smith K. HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care STDs 2012;26:222-233.
24. Centers for Disease Control and Prevention. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR 2012;61:586-589.
25. Krakower D, Mayer K. What primary care providers need to know about preexposure prophylaxis for HIV prevention: A narrative review. Ann Int Med 2012;157: 490-497.